Article
Stereoselective interaction between the CYP2C8 inhibitor gemfibrozil and racemic ibuprofen.
European journal of clinical pharmacology - 1 May 2007
Tornio Aleksi, Niemi Mikko, Neuvonen Pertti J, Backman Janne T
Abstract excerpt
OBJECTIVE: Ibuprofen, a nonsteroidal anti-inflammatory agent, is metabolised in vitro by cytochrome P450 (CYP) 2C8 and 2C9. We studied the possible effect of gemfibrozil, an in vivo inhibitor of CYP2C8, on the pharmacokinetics of ibuprofen in healthy volunteers. METHODS: In a randomised two-phase crossover study, 10 healthy volunteers took 600 mg gemfibrozil or placebo orally twice daily for 3 days. On day 3,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
